Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-23

Clinical Trial Update: Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating teniposide with cisplatin for newly diagnosed Central Malignant Germ Cell Tumor, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Teniposide (teniposide)

Snippet

Sponsor: Chengcheng Guo | Conditions: GCT, Germ Cell Tumor | Phase 2 | Status: RECRUITING